Neauvia Hydro Deluxe 2x2.5ml
Important Notice
Regulated medical device (EU MDR 2017/745). For sale exclusively to qualified healthcare professionals.
What this purchase includes
- Original productFrom the manufacturer or an official distributor, CE marked.
- Batch and expiry documentedRecorded per unit on the delivery note and the invoice.
- Controlled storageOur own Madrid warehouse, 12 to 18 °C under 24 h control.
- Dispatch in 24 to 48 hFrom Madrid, insured and with a tracking number.
- Reachable Monday to Friday9:00 to 17:00 by WhatsApp and email. People, not forms.
Neauvia Organic Hydro Deluxe is the skinbooster of the MATEX LAB range: linear, non-cross-linked hyaluronic acid at 18 mg/ml combined with calcium hydroxyapatite, glycine and L-proline. It is administered by microinjections into the epidermis and dermis of the face and neck with a 30G needle, and is presented in two 2.5 ml syringes. It is the only non-cross-linked reference in the Neauvia range and has its own protocol, distinct from that of the Intense and Stimulate fillers.
- Linear HA 18 mg/ml
- With CaHA Yes
- Contents 2 syringes × 2.5 ml
- Needle 30G included
- Plane Epidermis and dermis
Composition and technology
- Non-cross-linked (linear) hyaluronic acid: 18 mg/ml.
- Calcium hydroxyapatite (CaHA): present in the formulation; the manufacturer does not publish the concentration.
- Glycine and L-proline in phosphate buffer solution.
- No anaesthetic: the formulation does not contain lidocaine.
- Rheological profile: low extrusion force, consistent with superficial injection through a 30G needle.
Non-cross-linked product. Hydro Deluxe is the only reference in the Neauvia range without cross-linking: the hyaluronic acid is linear, so the PEGDE technology that characterises the Intense and Stimulate lines does not apply. Its function is not volumetric but the treatment of skin quality in the epidermis and dermis, and its persistence is correspondingly short: the manufacturer states up to 4 weeks, with a mean time of 2 weeks. This figure is the persistence of the implant, not the duration of the perceived clinical effect, and explains why the product is used in a scheme of repeated sessions rather than as a single application.
Glycine and L-proline. Both proteinogenic amino acids are added to the buffer solution to adjust the viscoelastic properties and the swelling resistance of the hydrogel.
Position within the Neauvia Organic range
| Product | HA · cross-linking · extrusion force · plane · area |
|---|---|
| Hydro Deluxe / Hydro Deluxe Man | 18 mg/ml · non-cross-linked (linear) + CaHA · low · epidermis and dermis · face and neck |
| Intense Rheology | 22 mg/ml · PEG · medium · intradermal and/or subcutaneous · face |
| Intense Lips | 24 mg/ml · PEG · medium · vermilion and/or perioral area · lips |
| Intense Flux | 26 mg/ml · PEG · medium · intradermal and/or subcutaneous · face |
| Intense LV | 26 mg/ml · PEG · medium/high · intradermal and/or subcutaneous · face |
| Stimulate / Stimulate Man | 26 mg/ml · PEG + calcium hydroxyapatite · medium/high · subdermis and/or supraperiosteal · face |
| Intense / Intense Man | 28 mg/ml · PEG · high · subcutaneous and/or supraperiosteal · face |
| Intense Rose | 28 mg/ml · PEG · high · intradermal · labia majora (gynaecological indication) |
The entire range shares the same formulation backbone: hyaluronic acid of biotechnological origin cross-linked with PEGDE (polyethylene glycol diglycidyl ether), buffered in phosphate solution and enriched with glycine and L-proline. The difference between references lies in the HA concentration, the resulting rheology and the intended injection plane, not in the cross-linking chemistry. Hydro Deluxe is the only non-cross-linked reference; Stimulate is the only one that incorporates calcium hydroxyapatite in the gel.
Indications and treatment areas
Biodegradable linear hyaluronic acid hydrogel intended for the treatment of skin quality by injection into the epidermis and dermis.
- Face
- Neck
The manufacturer limits the injection area to the face and neck; it publishes no indication for the décolletage or the dorsum of the hands.
Technique and treatment protocol
- Injection plane: epidermis and dermis.
- Areas: face and neck.
- Needle: 30G, included in the pack.
- Technique: superficial microinjections (multiple puncture or nappage) distributed evenly over the treated area.
- Persistence of the product: up to 4 weeks, with a mean time of 2 weeks according to manufacturer data. Given this persistence, treatment is planned as repeated sessions; the manufacturer does not publish a fixed number of sessions or a standardised interval, so the regimen must be set according to clinical judgement.
- Combination therapy: the manufacturer integrates the reference into two of its own synergistic protocols, one for the mid third of the face and one for restoration of the epidermis, in combination with cross-linked fillers from the range.
Technical data
| Manufacturer | MATEX LAB S.p.A. — via Carlo Urbani 2 ang. via Enrico Fermi, Brindisi (Italy) |
|---|---|
| Active substance | Non-cross-linked hyaluronic acid 18 mg/ml + calcium hydroxyapatite |
| Cross-linking | Non-cross-linked (linear hyaluronic acid) |
| Other components | Glycine, L-proline; phosphate buffer solution |
| Anaesthetic | Not contained |
| Presentation | 2 pre-filled syringes of 2.5 ml (5.0 ml in total) |
| Needle | 30G included |
| Extrusion force | Low |
| Injection plane | Epidermis and dermis |
| Areas | Face and neck |
| Persistence | Up to 4 weeks; 2 weeks on average |
| Classification | Class III medical device with CE marking (EU Regulation 2017/745, MDR) |
| Use | Qualified healthcare professionals only, trained in hyaluronic acid filler injection techniques |
Storage and pack contents
The pack contains: 2 pre-filled syringes of 2.5 ml, 30G needle, package leaflet and traceability labels.
- Sterile pre-filled syringes, ready for use.
- Single-use product. Do not reuse or re-sterilise.
- Store under the conditions indicated on the pack, protected from direct sunlight.
- Do not use after the expiry date shown on the pack.
- The traceability labels supplied must be attached to the patient record.
Contraindications and warnings
The manufacturer restricts use to physicians acting in accordance with local legislation and trained in hyaluronic acid filler injection techniques.
Must not be applied in the case of: known hypersensitivity to any of the components of the product; active skin infection, inflammation or lesion in the treatment area; pregnancy and breastfeeding; patients under the age of majority.
Individual assessment: autoimmune disease or immunosuppressive therapy; tendency to hypertrophic or keloid scarring; anticoagulant or antiplatelet therapy; presence of permanent implants in the area.
Do not inject intravascularly. Sterile single-use product: do not reuse or re-sterilise; discard syringes and needles after the procedure.
The full contraindications, warnings and possible adverse effects are listed in the package leaflet accompanying the pack and must be consulted before each application.
Medical device intended exclusively for qualified healthcare professionals. Technical information based on the official documentation of MATEX LAB S.p.A. (Neauvia product data sheets and the manufacturer's technical pages) and on peer-reviewed literature on PEG cross-linked hyaluronic acid hydrogels. This data sheet does not replace the instructions for use accompanying the product.